AI-generated summary
The authors report a pilot study of 50 postmenopausal women with vulvovaginal atrophy who received three fractional CO2 laser applications over 12 weeks. They found improvements in symptoms, vaginal health scores and quality of life, with no adverse events recorded. The authors note that further controlled studies are needed to confirm these results.
- Participants
- 50
- Who or what was studied
- Postmenopausal women with vulvovaginal atrophy (mean age 59.6 years) who were dissatisfied with previous local estrogen therapies
- Limits stated in the abstract
- The abstract describes a small pilot study with no control group and states that further controlled studies are needed to confirm the findings.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on tandfonline.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Laser, Pilot study. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.